ArticleThoracic cancer2025

Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma.

Canjun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.